Conditions: Type 2 Diabetes
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 1179
Healthy volunteers: no

Brief summary:
The purpose of this clinical research study is to learn if BMS-512148 (Dapagliflozin) can improve (decrease) blood glucose values in Asian patients with Type 2 Diabetes who have never been treated with medication or have been on medication for less than 24 weeks since their original diagnosis of Diabetes. The safety of this treatment will also be studied.

Detailed description:

Arms:
arm 1: None arm 2: None arm 3: None

Interventions: intervention 1: Dapagliflozin intervention 2: Dapagliflozin intervention 3: Metformin intervention 4: Dapagliflozin Placebo
Intervention descriptions: intervention 1: Tablets, Oral, 5 mg, Once daily, 24 weeks intervention 2: Tablets, Oral, 10 mg, Once daily, 24 weeks intervention 3: Tablets, Oral, 500-2000 mg (as needed for rescue based on protocol specific criteria), Up to 20 weeks intervention 4: Tablets, Oral, 0 mg, Once daily, 24 weeks

Protocol document: